These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17435540)

  • 1. Effective neoadjuvant therapy prior to metastasectomy: a new paradigm.
    Schulick RD
    Ann Surg; 2007 Mar; 245(3):353-4. PubMed ID: 17435540
    [No Abstract]   [Full Text] [Related]  

  • 2. Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors?
    Yoon SS; Tanabe KK
    Ann Surg Oncol; 2007 Jun; 14(6):1784-6. PubMed ID: 17356951
    [No Abstract]   [Full Text] [Related]  

  • 3. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection.
    Cavaliere D; Vagliasindi A; Mura G; Framarini M; Giorgetti G; Solfrini G; Tauceri F; Padovani F; Milandri C; Dubini A; Ridolfi L; Ricci E; Verdecchia GM
    Eur J Surg Oncol; 2007 Oct; 33(8):1044-6. PubMed ID: 17467951
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of advanced gastrointestinal stromal tumor: a marriage of targeted therapy and surgery?
    DeMatteo RP
    Ann Surg Oncol; 2007 Jan; 14(1):1-2. PubMed ID: 16957967
    [No Abstract]   [Full Text] [Related]  

  • 6. [GIST: our experience].
    Rossi MT; Fasano G; Morlino A; Scutari F
    G Chir; 2009; 30(1-2):41-5. PubMed ID: 19272232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib in advanced gastrointestinal stromal tumour: when is 800 mg the correct dose?
    Judson I
    Curr Opin Oncol; 2008 Jul; 20(4):433-7. PubMed ID: 18525340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
    Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
    Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors.
    Nilsson B; Andersson A; Ahlman H
    J Surg Oncol; 2008 Sep; 98(3):145-6. PubMed ID: 18452216
    [No Abstract]   [Full Text] [Related]  

  • 10. Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.
    Renouf DJ; Wilson L; Blanke CD
    Clin Cancer Res; 2009 Jun; 15(12):3908-11. PubMed ID: 19509180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule tyrosine kinase inhibitor and depression.
    Quek R; Morgan JA; George S; Butrynski JE; Polson K; Meyer F; Demetri GD; Block SD
    J Clin Oncol; 2009 Jan; 27(2):312-3. PubMed ID: 19064960
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of huge GIST of the stomach successfully resected following effective neoadjuvant chemotherapy.
    Tanaka N; Saka M
    Jpn J Clin Oncol; 2008 Nov; 38(11):790. PubMed ID: 18952707
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary C-kit mutation is a cause of acquired resistance to imatinib in gastrointestinal stromal tumor.
    Zheng S; Pan YL; Tao DY; Wang JL; Huang KE
    Scand J Gastroenterol; 2009; 44(6):760-3. PubMed ID: 19096980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor.
    Battistella M; Frémont G; Vignon-Pennamen MD; Gornet JM; Dubertret L; Viguier M
    Arch Dermatol; 2008 Oct; 144(10):1400-2. PubMed ID: 18936416
    [No Abstract]   [Full Text] [Related]  

  • 15. [Strategy for patients with GIST after failure of imatinib].
    Abe S; Kubota T
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):540-3. PubMed ID: 19381023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors (GISTs): a pathology view point.
    Sornmayura P
    J Med Assoc Thai; 2009 Jan; 92(1):124-35. PubMed ID: 19260254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase inhibitors for chronic myelogenous leukemia.
    Quintás-Cardama A; Kantarjian H; Cortes J
    N Engl J Med; 2007 Oct; 357(15):1557; author reply 1557-8. PubMed ID: 17933034
    [No Abstract]   [Full Text] [Related]  

  • 18. Sunitinib: new drug. For some gastrointestinal stromal tumours.
    Prescrire Int; 2007 Aug; 16(90):138-41. PubMed ID: 17724833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic monitoring of drug plasma concentrations and improved clinical outcomes in GIST.
    Demetri GD
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):S6-7. PubMed ID: 19391310
    [No Abstract]   [Full Text] [Related]  

  • 20. Applying the discovery of the Philadelphia chromosome.
    Sherbenou DW; Druker BJ
    J Clin Invest; 2007 Aug; 117(8):2067-74. PubMed ID: 17671641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.